Could Ceramides Become the New Cholesterol?

被引：128
|
作者：
Summers, Scott A. [1 ]
机构：
[1] Univ Utah, Dept Nutr & Integrat Physiol, Salt Lake City, UT 84112 USA
来源：
CELL METABOLISM | 2018年 / 27卷 / 02期
关键词：
INDUCED INSULIN-RESISTANCE; CORONARY-HEART-DISEASE; PLASMA CERAMIDES; ACID SPHINGOMYELINASE; METABOLISM; DIET; LIPOPROTEIN; INHIBITION; OBESITY; SPHINGOLIPIDS;
D O I：
10.1016/j.cmet.2017.12.003
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The Mayo Clinic recently introduced a diagnostic test that quantifies plasma ceramides in order to identify patients at risk of major adverse cardiac events. By comparing recent discoveries about these biomarker ceramides with the exhaustive body of literature surrounding cholesterol, Summers aims to highlight important advances and critically needed areas of investigation on this exciting class of bioactive lipids.
引用
收藏
页码：276 / 280
页数：5
相关论文
共 50 条
12345